Biomarin Pharma (BMRN) Tops Q3 EPS by 7c; Tightens FY10 Guidance

October 28, 2010 4:26 PM

Biomarin Pharma (Nasdaq: BMRN) reports Q3 EPS of $0.06, 7 cents ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found